NCT05884372View on ClinicalTrials.gov

Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis.

PHASE4RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 24, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions

Osteoporosis in Postmenopausal Women

Interventions

DRUG

Eldecalcitol

the same as arm descriptions.

DRUG

Native Vitamin D

the same as arm descriptions.

DRUG

Denosumab

the same as arm descriptions.

DRUG

Calcium

the same as arm descriptions.

Trial Locations (1)

Unknown

RECRUITING

Zeng,Yuhong, Xi'an

All Listed Sponsors

collaborator

Chugai Pharma China Co., Ltd.

UNKNOWN

lead

Xi'an Honghui Hospital

OTHER

NCT05884372 - Comparison of Efficacy of Denosumab With Eldecalcitol or Native Vitamin D in Postmenopausal Women With Osteoporosis. | Biotech Hunter | Biotech Hunter